P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

January 2011

Features

Drug Class Review

Use of Angiotensin Receptor Blockers in Cardiovascular Protection

Current Evidence and Future Directions

The question of whether the pleiotropic effects of combining an ARB with an ACE inhibitor would provide a greater vascular advantage over either class of agent alone has not been directly addressed in clinical trials to date.
Mark A. Munger, PharmD

Drug Use Evaluation

Utilization of Methylnaltrexone (Relistor) for Opioid-Induced Constipation in an Oncology Hospital

Methylnaltrexone relieves opioid-induced constipation; too often, however, it is prescribed inappropriately. Implementing order sets may help to reduce misuse.
Jack L. Watkins, PharmD; Karen R. Eckmann, PharmD; Morgan L. Mace, PharmD; Jane Rogers, PharmD; Ginger Langley, PharmD, BCPS, BCNSP; and Wendy Smith, PharmD, BCPS

Commentary

Hospitals Scramble to Meet Deadlines for Adopting Electronic Health Records

Pharmacy Systems Will Be Updated Slowly but Surely

Millions of dollars are at stake as hospitals rush to adopt EHRs. However, few hospitals have certified systems in place to meet the definition of meaningful use.
Stephen Barlas

Pharmaceutical Approval Update

Topics include therapies for breast cancer, prevention of skeletal-related events in cancer patients, and pseudobulbar affect.
Marvin M. Goldenberg, PhD, RPh, MS

Meeting Highlights

American Heart Association 2010 Scientific Sessions and American Society of Nephrology: Renal Week 2010

The cardiology meeting covered rivaroxaban, clopidogrel, and statins. Nephrology topics included ezetimibe/simvastatin, eculizumab, and bardoxolone.
Walter Alexander

Departments

Editorial

Looking Back on 2010

Dr. David Nash looks back on a year of important advances by Thomas Jefferson University Hospital’s medication quality subcommittee.
David B. Nash, MD, MBA

Medication Errors

Lack of Standard Dosing Units and Measurements Creates Mishaps in Intravenous Drug Administration

Standardizing dosing measurements and units is essential for avoiding mistakes in administering intravenous agents.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Hospital Outpatient Pharmacies Win Higher Medicare Payments for 2011

But They Are Not Yet Recovering Overhead Costs for Expensive Drugs

Hospital pharmacies will be receiving higher Medicare payments in 2011, but they are still not being compensated sufficiently for their overhead costs for expensive drugs.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates